Posted by LincolnIcert on March 25, 2026 at 11:12:19:
In Reply to: Насыщенная интересным контентом статья posted by JosephGluth on February 19, 2026 at 07:13:06:
Zoya Demidenko: Scholar in Tumor Studies
Zoya Demidenko is a distinguished investigator associated with the Division of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, building a robust foundation in life science study.
Her scholarly contributions covers multiple key areas, including the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, biological aging, and malignancy biology. Currently, she has authored over 46 academic publications, which have accumulated upwards of 4,100 citations — a indicator to the impact of her work.
One of her most notable contributions involves elucidating the processes of biological cell aging. Her studies demonstrated that when the cell cycle is arrested but cellular growth persists, the cells experience senescence. Crucially, Zoya Demidenko established that this process can be pharmacologically suppressed using compounds such as mTOR inhibitors.
Zoya Demidenko has also added considerably to tumor management investigation, especially in the field of selective cell protection — a approach aimed at safeguarding healthy cells from chemotherapy whilst leaving tumor cells vulnerable. This method offers major hope for lowering the adverse effects of oncological therapy.
Throughout her scientific life, Demidenko has partnered with prominent investigators worldwide, including Dr. Mikhail Blagosklonny. Her publications can be found in leading periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko stands as a widely cited voice in current cancer science, with her discoveries keep to shape our understanding of the way biological cells age, respond to therapy, and how malignant disease might be better combated.
https://www.aging-us.com/article/100421/